Penske Automotive posts record profit
BLOOMFIELD HILLS—Penske Automotive Group Inc. (NYSE: PAG) posted net income of $246.6 million or $3.07 a share in the third quarter of 2020, up from $116.2 million or $1.42 in …
Esperion revenues rise sharply with cholesterol drugs finally on market
ANN ARBOR–Officials at Esperion Therapeutics Inc. (Nasdaq: ESPR) announced record revenue in the second quarter ended June 30, as its cholesterol-fighting drugs Nexletol and Nexlizet have been approved for use …
Lear sales plunge, loss posted
SOUTHFIELD—Lear Corp. (NYSE: LEA), the Southfield-based manufacturer of automotive interiors and electronics, reported a net loss of $294 million or $4.89 a share in the second quarter, as sales plunged …
CMS Energy revenue, net income rise
JACKSON—Officials at CMS Energy (NYSE: CMS) announced second quarter net income of $136 million or 48 cents a share, up from $93 million or 33 cents a share in the …
Masco sales, profits decline
LIVONIA—Masco Corp., the Livonia-based manufacturer of home improvement and building products, reported net income of $234 million or 85 cents a share in the second quarter, down from $240 million …
Dow sales, profits plunge amid pandemic
MIDLAND—Revenue and profit both declined substantially at Dow Inc., the Midland-based chemical giant, for the second quarter ended June 30, as the coronavirus pandemic slowed down business worldwide. Revenue for …
Horizon Global cuts loss despite lower sales
PLYMOUTH–Horizon Global Corp. (NYSE: HZN) reported a loss of $16.7 million or 66 cents a share in the first quarter of 2020, an improvement from a loss of $25.1 million …
Alta loss grows on acquisition expenses
LIVONIA—Alta Equipment Group Inc. (NYSE: ALTG), a provider of industrial and construction equipment and related services, posted a loss of $17 million or 91 cents a share in the first …
Spartan Motors profit rises
NOVI—Spartan Motors Inc. (Nasdaq: SPAR), the specialty vehicle manufacturer, reported net income of $7.9 million or 22 cents a share in the first quarter, up from $1.4 million or 4 …
Esperion reports first financial results since new cholesterol drug approval
ANN ARBOR—Esperion Therapeutics Inc. (NASDAQ:ESPR) reported a loss of $78.2 million or $2.84 a share in the first quarter of 2020, vs. net income of $87.4 million or $3.07 a …